54 results on '"Iftode, Cristina"'
Search Results
52. Neoadjuvant Chemoradiotherapy with Volumetric-modulated Arc Therapy for Medium-distal Oesophageal and Gastro-oesophageal Junction Carcinoma.
- Author
-
Tozzi A, Iftode C, Cozzi L, Ascolese AM, Battista S, Cavina R, Clerici E, Comito T, D'Agostino GR, De Rose F, Franzese C, Garassino I, Romario UF, Navarria P, Rosati R, Spaggiari P, Tomatis S, and Scorsetti M
- Subjects
- Adult, Aged, Chemoradiotherapy methods, Esophageal Neoplasms pathology, Esophagogastric Junction pathology, Female, Humans, Male, Middle Aged, Neoadjuvant Therapy methods, Neoplasm Staging methods, Radiotherapy, Intensity-Modulated adverse effects, Radiotherapy, Intensity-Modulated methods, Retrospective Studies, Treatment Outcome, Esophageal Neoplasms drug therapy, Esophageal Neoplasms radiotherapy, Esophagogastric Junction drug effects, Esophagogastric Junction radiation effects
- Abstract
Aim: to appraise the role of volumetric-modulated arc therapy (VMAT) in the neoadjuvant chemoradiotherapy management of advanced medium and distal oesophageal cancer in terms of toxicity and response to treatment., Patients and Methods: Thirty patients were treated according to the neoadjuvant chemoradiation followed by surgery versus surgery-alone trial scheme with VMAT radiation therapy. Patients presented mainly T3-T4 stage (80%) and N1-2 (96.6%) disease. The chemotherapy scheme consisted of 3-5 cycles, while a radiotherapy course of 41.4 Gy in 23 fractions was administered to all patients., Results: The median age of patients was 65 years, and there was a predominance of males (80%), smokers or ex-smokers (90%) and modest alcohol habit (80% negative). Primary tumor localisation was in the medium and distal third of the oesophagus in 57% of the cases, the rest being in the gastro-oesophageal junction. Modest toxicity profiles were observed, with limited incidence of grade 2-3 events. Partial or complete response was observed in more than 90% of the cases (radiological/metabolic) and was confirmed after surgical intervention (67% partial or complete and 27% stable response). Tumor down-staging was recorded in 67% of patients and nodal down-staging in 50%., Conclusion: VMAT was applied in the context of neoadjuvant chemoradiotherapy for the treatment of medium and distal oesophageal carcinoma with satisfactory results in terms of tolerance and toxicity., (Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)
- Published
- 2015
53. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
- Author
-
Alongi F, Cozzi L, Fogliata A, Iftode C, Comito T, Clivio A, Villa E, Lobefalo F, Navarria P, Reggiori G, Mancosu P, Clerici E, Tomatis S, Taverna G, Graziotti P, and Scorsetti M
- Subjects
- Aged, Aged, 80 and over, Combined Modality Therapy, Dose Fractionation, Radiation, Gastrointestinal Diseases etiology, Humans, Male, Middle Aged, Prostatectomy, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Retrospective Studies, Prostatic Neoplasms radiotherapy, Radiation Injuries etiology, Radiotherapy, Intensity-Modulated adverse effects
- Abstract
Aims: To retrospectively evaluate and compare the incidence of acute genitourinary (aGU), upper gastrointestinal (uGI) and rectal (lGI) injuries after radiotherapy with hypo-fractionation by volumetric modulation arc therapy (VMAT, the Hypo-RapidArc group) and conventional fractionation by three-dimensional conformal radiotherapy (3DCRT) in patients with localized prostate cancer treated, after radical prostatectomy, with prostatic bed irradiation., Patients and Methods: Between 2007 and 2012, 84 consecutive patients with clinically localized prostate cancer submitted to radical prostatectomy were also treated with irradiation to the prostate bed. Forty-five received 3DCRT and 39 Hypo-RapidArc. The median age was 67 and 69 years for 3DCRT and Hypo-RapidArc groups respectively. The median dose to the prostatic bed was 70 Gy in both groups: 2 Gy/fraction in the 3DCRT group and 2.5 Gy/fraction in the Hypo-RapidArc group. After radical prostatectomy, the median time-to-RT was 15 and 16 months respectively. Acute and late toxicities were scored according to the Radiation Therapy and Oncology Group/European Organization for Research and Treatment of Cancer system., Results: Grade 2aGU was recorded in 16% of cases in the 3DRCT group and in 10% in the Hypo-RapidArc group. No acute grade 2 upper gastrointestinal (uGI) toxicities were found in the 3DCRT versus 5% in the Hypo-RapidArc group. The incidence of grade 2 lower gastrointestinal (lGI) toxicities was 22% in the 3DCRT group versus 15% in the Hypo-RapidArc group. No grade 3 or greater toxicities were found in either group. In both groups, good planning target volume coverage was achieved: V95% was recorded as 96.3 ± 3.6% (mean ± standard deviation) and 95.7 ± 8.9 for the 3DRCT and the Hypo-RapidArc groups, respectively. The mean rectal volume dose receiving at least 70 Gy was 9.1 ± 10.8% and 0.1 ± 0.6% respectively. The mean dose to the bladder was 49.5 ± 12.3 Gy and 37.2 ± 5.2 Gy respectively. Significant correlation between late rectal toxicity and the maximum dose to the rectum, V70Gy, was found in the 3DCRT group, while no significant correlations were found for acute toxicity., Conclusion: The results presented in this study demonstrate the feasibility of a moderate hypo-fractionation regimen with RapidArc in the postoperative setting. Longer-term data are needed to confirm late toxicity profiles.
- Published
- 2013
54. Analysis of the efficiency of adenovirus transcription.
- Author
-
Iftode C and Flint SJ
- Subjects
- Cell Nucleus metabolism, DNA, Viral genetics, HeLa Cells, Humans, Nucleic Acid Hybridization, RNA, Messenger genetics, Reverse Transcriptase Polymerase Chain Reaction, Adenoviridae genetics, Transcription, Genetic
- Abstract
This method is designed to measure rates of transcription from adenoviral promoters as a function of the concentrations within infected cells of the promoter(s) of interest. The latter parameter is assessed by quantification of viral DNA by hybridization of membrane-bound DNA following purification of DNA from nuclear fractions of adenovirus-infected cells. Two alternative protocols, primer extension and quantitative reverse transcription polymerase chain reaction, are described for determination of the concentrations of viral mRNAs purified from the cytoplasmic fractions of the same infected cell samples. An alternative procedure to measure rates of transcription directly using run-on transcription in isolated nuclei is also presented.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.